MA26790A1 - Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie - Google Patents
Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurieInfo
- Publication number
- MA26790A1 MA26790A1 MA26402A MA26402A MA26790A1 MA 26790 A1 MA26790 A1 MA 26790A1 MA 26402 A MA26402 A MA 26402A MA 26402 A MA26402 A MA 26402A MA 26790 A1 MA26790 A1 MA 26790A1
- Authority
- MA
- Morocco
- Prior art keywords
- oxaluria
- dietetic
- hyper
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999RM000338A IT1309427B1 (it) | 1999-05-28 | 1999-05-28 | Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26790A1 true MA26790A1 (fr) | 2004-12-20 |
Family
ID=11406789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA26402A MA26790A1 (fr) | 1999-05-28 | 2001-11-08 | Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie |
Country Status (34)
Country | Link |
---|---|
US (2) | US6562336B2 (fr) |
EP (1) | EP1181027B1 (fr) |
JP (1) | JP4737836B2 (fr) |
KR (1) | KR100781703B1 (fr) |
CN (1) | CN100350919C (fr) |
AR (1) | AR024555A1 (fr) |
AT (1) | ATE265857T1 (fr) |
AU (1) | AU773459B2 (fr) |
BR (1) | BR0011038B1 (fr) |
CA (1) | CA2373255C (fr) |
CZ (1) | CZ20014076A3 (fr) |
DE (1) | DE60010456T2 (fr) |
DK (1) | DK1181027T3 (fr) |
DZ (1) | DZ3165A1 (fr) |
EA (1) | EA004257B1 (fr) |
EE (1) | EE200100618A (fr) |
ES (1) | ES2219344T3 (fr) |
HK (1) | HK1048066B (fr) |
HU (1) | HU225134B1 (fr) |
IL (3) | IL146703A0 (fr) |
IS (1) | IS6150A (fr) |
IT (1) | IT1309427B1 (fr) |
MA (1) | MA26790A1 (fr) |
MX (1) | MXPA01012184A (fr) |
NO (1) | NO20015782L (fr) |
NZ (1) | NZ516020A (fr) |
PL (1) | PL352014A1 (fr) |
PT (1) | PT1181027E (fr) |
SI (1) | SI1181027T1 (fr) |
SK (1) | SK16612001A3 (fr) |
TR (1) | TR200103439T2 (fr) |
UA (1) | UA71621C2 (fr) |
WO (1) | WO2000072855A2 (fr) |
ZA (1) | ZA200110504B (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1283225B1 (it) * | 1996-03-11 | 1998-04-16 | Renata Maria Anna Ve Cavaliere | Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle |
US8486389B2 (en) | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
US8697051B2 (en) * | 1999-06-09 | 2014-04-15 | Vsl Pharmaceuticals Inc. | Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
ITRM20010763A1 (it) * | 2001-12-21 | 2003-06-21 | Simone Claudio De | Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono. |
US9655932B2 (en) | 2002-03-13 | 2017-05-23 | Kibow Biotech, Inc. | Composition and method for preventing or treating gout or hyperuricemia |
US11103542B2 (en) | 2002-03-13 | 2021-08-31 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
US20050074442A1 (en) * | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
JPWO2004112809A1 (ja) * | 2003-06-24 | 2006-07-20 | 大塚製薬株式会社 | 血清尿酸低減組成物 |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
AU2005224162A1 (en) | 2004-03-19 | 2005-09-29 | Danisco A/S | Emulsifier composition for shortening |
US7468182B2 (en) * | 2004-10-27 | 2008-12-23 | North Carolina State University | Lactobacillus acidophilus nucleic acids and uses thereof |
WO2006130187A1 (fr) | 2005-05-31 | 2006-12-07 | The Iams Company | Lactobacilli felins a activite probiotique |
BRPI0611492B1 (pt) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
EP1962873B1 (fr) | 2005-12-14 | 2013-05-29 | OxThera, Inc., | Compositions pharmaceutiques à base de bacteries redusiant l'oxalate |
CN104013581A (zh) * | 2005-12-16 | 2014-09-03 | 奥克斯赛拉公司 | 用于减少草酸和/或其盐的组合物和方法 |
AU2008230747A1 (en) * | 2007-03-27 | 2008-10-02 | The Procter & Gamble Company | Methods and kits for administering probiotics |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
CN101606952B (zh) * | 2008-06-17 | 2012-09-19 | 上海交通大学医学院附属第三人民医院 | 乳双歧杆菌在制备预防泌尿***结石药物中的应用 |
JP5632289B2 (ja) | 2008-09-30 | 2014-11-26 | 株式会社明治 | 高いシュウ酸分解能を有する乳酸菌 |
CN101554237B (zh) * | 2009-03-16 | 2013-11-06 | 武汉康复得生物科技有限公司 | 植物纤维或微生物不溶组分中的草酸降解酶的制备方法 |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
IT1403661B1 (it) | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
ITMI20121173A1 (it) * | 2012-07-04 | 2014-01-05 | Neupharma Srl | Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio |
ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
ITMI20130795A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat |
JP5765832B2 (ja) * | 2013-12-26 | 2015-08-19 | 雪印メグミルク株式会社 | 加齢に伴う代謝異常症の予防・改善・治療剤 |
ES2808677T3 (es) * | 2014-10-01 | 2021-03-01 | Triphase Pharmaceuticals Pvt Ltd | Cepas termoestables, productos y métodos de las mismas |
ITUB20155752A1 (it) * | 2015-11-19 | 2017-05-19 | Probiotical Spa | Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli. |
CN107868776A (zh) | 2016-09-23 | 2018-04-03 | 武汉康复得生物科技股份有限公司 | 糖基化草酸脱羧酶及其制备和应用 |
US11179426B2 (en) | 2016-12-29 | 2021-11-23 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
WO2020123483A1 (fr) * | 2018-12-10 | 2020-06-18 | Novome Biotechnologies, Inc. | Méthodes et compositions pour le traitement de l'hyperoxalurie |
CN113308416B (zh) * | 2021-07-20 | 2023-02-24 | 四川大学 | 一株具有抑制肾结石形成能力的植物乳杆菌及其应用 |
CN115851508B (zh) * | 2022-10-13 | 2024-01-09 | 山东中科嘉亿生物工程有限公司 | 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5810520A (ja) * | 1981-07-10 | 1983-01-21 | Miyarisan Kk | 胆石症の治療薬 |
DE69219768T2 (de) * | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milchbakterien |
IT1283225B1 (it) * | 1996-03-11 | 1998-04-16 | Renata Maria Anna Ve Cavaliere | Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle |
EP0856259B1 (fr) * | 1996-12-23 | 1998-08-12 | SITIA-YOMO S.p.A. | Composition pour l'usage dans l'alimentation comprenant de bactéries vivantes lactiques lyophisées |
KR20010012845A (ko) * | 1997-05-23 | 2001-02-26 | 아익션 바이오테크놀로지, 인코퍼레이티드 | 옥살산염 관련 질병의 예방을 위한 옥살산염-분해 미생물또는 옥살산염-분해 효소 |
RU2139346C1 (ru) * | 1999-03-02 | 1999-10-10 | Шендеров Борис Аркадьевич | Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии |
-
1999
- 1999-05-28 IT IT1999RM000338A patent/IT1309427B1/it active
-
2000
- 2000-05-24 PL PL00352014A patent/PL352014A1/xx not_active Application Discontinuation
- 2000-05-24 SK SK1661-2001A patent/SK16612001A3/sk unknown
- 2000-05-24 CN CNB008081824A patent/CN100350919C/zh not_active Expired - Fee Related
- 2000-05-24 TR TR2001/03439T patent/TR200103439T2/xx unknown
- 2000-05-24 CA CA002373255A patent/CA2373255C/fr not_active Expired - Fee Related
- 2000-05-24 AT AT00935478T patent/ATE265857T1/de active
- 2000-05-24 HU HU0201409A patent/HU225134B1/hu not_active IP Right Cessation
- 2000-05-24 EA EA200101262A patent/EA004257B1/ru not_active IP Right Cessation
- 2000-05-24 SI SI200030363T patent/SI1181027T1/xx unknown
- 2000-05-24 DE DE60010456T patent/DE60010456T2/de not_active Expired - Lifetime
- 2000-05-24 KR KR1020017014857A patent/KR100781703B1/ko not_active IP Right Cessation
- 2000-05-24 JP JP2000620965A patent/JP4737836B2/ja not_active Expired - Fee Related
- 2000-05-24 IL IL14670300A patent/IL146703A0/xx unknown
- 2000-05-24 DZ DZ003165A patent/DZ3165A1/fr active
- 2000-05-24 UA UA2001129040A patent/UA71621C2/uk unknown
- 2000-05-24 EP EP00935478A patent/EP1181027B1/fr not_active Expired - Lifetime
- 2000-05-24 ES ES00935478T patent/ES2219344T3/es not_active Expired - Lifetime
- 2000-05-24 PT PT00935478T patent/PT1181027E/pt unknown
- 2000-05-24 WO PCT/IT2000/000213 patent/WO2000072855A2/fr not_active Application Discontinuation
- 2000-05-24 NZ NZ516020A patent/NZ516020A/xx unknown
- 2000-05-24 BR BRPI0011038-8A patent/BR0011038B1/pt not_active IP Right Cessation
- 2000-05-24 AU AU51016/00A patent/AU773459B2/en not_active Ceased
- 2000-05-24 DK DK00935478T patent/DK1181027T3/da active
- 2000-05-24 EE EEP200100618A patent/EE200100618A/xx unknown
- 2000-05-24 AR ARP000102552A patent/AR024555A1/es not_active Application Discontinuation
- 2000-05-24 CZ CZ20014076A patent/CZ20014076A3/cs unknown
- 2000-05-24 MX MXPA01012184A patent/MXPA01012184A/es active IP Right Grant
-
2001
- 2001-11-08 MA MA26402A patent/MA26790A1/fr unknown
- 2001-11-08 IS IS6150A patent/IS6150A/is unknown
- 2001-11-22 IL IL146703A patent/IL146703A/en not_active IP Right Cessation
- 2001-11-26 US US09/992,029 patent/US6562336B2/en not_active Ceased
- 2001-11-27 NO NO20015782A patent/NO20015782L/no not_active Application Discontinuation
- 2001-12-21 ZA ZA200110504A patent/ZA200110504B/xx unknown
-
2003
- 2003-01-07 HK HK03100152.1A patent/HK1048066B/zh not_active IP Right Cessation
-
2005
- 2005-02-04 US US11/050,623 patent/USRE39585E1/en not_active Expired - Lifetime
-
2009
- 2009-06-18 IL IL199437A patent/IL199437A/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26790A1 (fr) | Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie | |
IL205298A0 (en) | Pharmaceutical compositions comprising an antibody to ab and uses thereof in the prevention or treatment of a disease characterized by amyloid deposit | |
HUP0103654A2 (hu) | Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására | |
IL122733A0 (en) | Pharmaceutical compositions for use in the treatment of allergic asthma | |
DZ2675A1 (fr) | Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant. | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
FR2812197B1 (fr) | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches | |
FR2742657B1 (fr) | Compositions pour le traitement des matieres keratiniques contenant l'association d'un polymere polyampholyte et d'un polymere cationique | |
FR2792835B3 (fr) | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression | |
FR2717080B1 (fr) | Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales. | |
FR2746658B1 (fr) | Valve de drainage implantable pour le traitement de l'hydrocephalie | |
FR2741355B1 (fr) | Composition pour le traitement d'objets que l'on souhaite nettoyer et/ou desinfecter | |
FR2758465B1 (fr) | Composition pour le traitement de l'amiante | |
DZ1988A1 (fr) | Thérapie de combinaison pour le traitement de l'hiv. | |
FR2744361B1 (fr) | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif | |
DZ2564A1 (fr) | Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés. | |
DZ3320A1 (fr) | Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine | |
FR2786096B1 (fr) | Composition pour la prevention et le traitement topique de la cellulite | |
FR2718024B1 (fr) | Médicament et composition pharmaceutique pour le traitement de l'inflammation. | |
FR2792199B3 (fr) | Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur | |
FR2720944B1 (fr) | Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie. | |
FR2774289B1 (fr) | Medicament pour le traitement des dereglements de l'apoptose | |
FR2751637B1 (fr) | Cellule d'electrocoagulation pour le traitement d'effluents | |
FR2751544B1 (fr) | Composition therapeutique pour le traitement des verrues vulgaires | |
FR2826261B1 (fr) | Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche |